“…MeCP2 likely plays a pivotal role in regulating activity-dependent gene transcription important for neural function, maturation of spine density, neuronal connectivity, dendritic arborization, behavior (Cohen et al, 2011; Jiang et al, 2013; Kishi and Macklis, 2010; Luikenhuis et al, 2004; Mullaney et al, 2004; Shahbazian et al, 2002b; Zhou et al, 2006), and multple forms of synaptic plasticity, including synaptic scaling (Blackman et al, 2012; Qiu et al, 2012; Zhong et al, 2012) and Hebbian plasticity (Li et al, 2011; Moretti et al, 2006; Munoz et al, 2016; Weng et al, 2011). Mouse models of Rett Syndrome with decreased or blocked expression of MeCP2 show impaired LTP in area CA1 of the hippocampus (Asaka et al, 2006; Weng et al, 2011), changes in glutamate receptor expression including decreased NR2A (Asaka et al, 2006), behavioral deficits (Neul et al, 2010), and increased spontaneous seizure susceptibility (D’Cruz et al, 2010; Shahbazian et al, 2002a; Zhang et al, 2014).…”